Evaluating the Impact of a Value-based Prescription Drug Formulary

Value-based Formulary-Essentials: Testing and Expanding on Value in Prescription Drug Benefit Design

NCT04904055•Kaiser Permanente

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Value-Based Health Insurance

Interventions

Value-based Formulary

Locations

United States

Locations (1)

Kaiser Permanente

Seattle, Washington, United States

Key Dates

Start Date

January 1, 2015

Primary Completion Date

December 31, 2019

Completion Date

December 31, 2019

Last Updated

May 27, 2021

Sponsors

Lead Sponsor

Kaiser Permanente

Collaborators

Donaghue Medical Research Foundation

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 27, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions